California Public Employees Retirement System’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-102,132
| Closed | -$494K | – | 3519 |
|
|
2020
Q1 | $494K | Buy |
102,132
+18,232
| +22% | +$118K | ﹤0.01% | 2415 |
|
|
2019
Q4 | $892K | Buy |
83,900
+44,400
| +112% | +$441K | ﹤0.01% | 2439 |
|
|
2019
Q3 | $411K | Buy |
39,500
+9,800
| +33% | +$128K | ﹤0.01% | 2645 |
|
|
2019
Q2 | $455K | Buy |
29,700
+3,300
| +13% | +$47.7K | ﹤0.01% | 2573 |
|
|
2019
Q1 | $339K | Hold |
26,400
| – | – | ﹤0.01% | 2726 |
|
|
2018
Q4 | $251K | Sell |
26,400
-5,055
| -16% | -$65.5K | ﹤0.01% | 2840 |
|
|
2018
Q3 | $522K | Sell |
31,455
-6
| -0% | -$96 | ﹤0.01% | 2644 |
|
|
2018
Q2 | $505K | Buy |
31,461
+361
| +1% | +$6.44K | ﹤0.01% | 2628 |
|
|
2018
Q1 | $476K | Hold |
31,100
| – | – | ﹤0.01% | 2639 |
|
|
2017
Q4 | $485K | Hold |
31,100
| – | – | ﹤0.01% | 2676 |
|
|
2017
Q3 | $345K | Hold |
31,100
| – | – | ﹤0.01% | 2819 |
|
|
2017
Q2 | $286K | Hold |
31,100
| – | – | ﹤0.01% | 2874 |
|
|
2017
Q1 | $266K | Hold |
31,100
| – | – | ﹤0.01% | 2915 |
|
|
2016
Q4 | $333K | Hold |
31,100
| – | – | ﹤0.01% | 2880 |
|
|
2016
Q3 | $337K | Hold |
31,100
| – | – | ﹤0.01% | 2900 |
|
|
2016
Q2 | $211K | Hold |
31,100
| – | – | ﹤0.01% | 3115 |
|
|
2016
Q1 | $145K | Hold |
31,100
| – | – | ﹤0.01% | 3256 |
|
|
2015
Q4 | $196K | Hold |
31,100
| – | – | ﹤0.01% | 3210 |
|
|
2015
Q3 | $275K | Hold |
31,100
| – | – | ﹤0.01% | 3091 |
|
|
2015
Q2 | $366K | Hold |
31,100
| – | – | ﹤0.01% | 3033 |
|
|
2015
Q1 | $443K | Hold |
31,100
| – | – | ﹤0.01% | 3045 |
|
|
2014
Q4 | $443K | Hold |
31,100
| – | – | ﹤0.01% | 3045 |
|
|
2014
Q3 | $388K | Hold |
31,100
| – | – | ﹤0.01% | 3081 |
|
|
2014
Q2 | $456K | Buy |
31,100
+12,700
| +69% | +$195K | ﹤0.01% | 3043 |
|
|
2014
Q1 | $352K | Hold |
18,400
| – | – | ﹤0.01% | 3158 |
|
|
2013
Q4 | $352K | Sell |
18,400
-400
| -2% | -$10.7K | ﹤0.01% | 3113 |
|
|
2013
Q3 | $851K | Buy |
+18,800
| New | +$613K | ﹤0.01% | 2485 |
|
California Public Employees Retirement System's STML Position: Q2 2020 in Review
California Public Employees Retirement System sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 102,132 shares — an estimated $494K sold.
California Public Employees Retirement System first reported a position in STML in Q3 2013 and held it in 27 quarters. The position peaked at $892K in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- California Public Employees Retirement System reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- California Public Employees Retirement System sold 102,132 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $494K.
- California Public Employees Retirement System first reported a position in Stemline Therapeutics, Inc. in Q3 2013 and held it in 27 quarters.
- California Public Employees Retirement System's Stemline Therapeutics, Inc. position peaked at $892K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on California Public Employees Retirement System's 13F filing for Q2 2020, filed 12 Aug 2020.